GE HealthCare Technologies posted preliminary second-quarter 2026 results that beat management's prior expectations, with total revenue of $5.295 billion representing a 5.7% year-over-year increase and organic revenue growth of 3.5%. The company also announced that Chief Financial Officer James Saccaro will step down on August 14, with Controller and Chief Accounting Officer George Newcomb named interim CFO. GE HealthCare reaffirmed its full-year 2026 outlook, including organic revenue growth of 3% to 4%, Adjusted EPS of $4.80 to $5.00, and an Adjusted EBIT margin between 15.4% and 15.7%. Hedge fund data showed 60 funds held stakes in the company in the second quarter, up from 48 in the first quarter, indicating growing institutional confidence.
GE HealthCare Technologies Inc.Preliminary Q2 results beat expectations and full-year outlook reaffirmed, indicating strong financial performance.